'It is apartheid': Activists blast pharma firms in protest at AstraZeneca's UK HQ over fairer access to Covid-19 jabs
The protests, led by Global Justice Now, began on Tuesday morning when two people chained themselves to the front doors of the Anglo-Swedish company's HQ in the city of Cambridge.
Others climbed onto the porch above the doors and unfurled a banner reading: "People's vaccine not profit vaccine."
Some activists played drums as police scuffled with protesters and made two arrests, according to a reporter for the Guardian.
Among speakers addressing the small crowd outside AstraZeneca's office was Dr Priyamvada Gopal, a lecturer in postcolonial literature at the University of Cambridge's Churchill College.
"The virus is really laughing with glee," she said. "The more we have patents, the more we refuse to share know-how, the more we privatise medicine, the more it is able to run rampant."
"What we now have, as many people have said, is vaccine apartheid. It is apartheid, it is protecting people on class lines, on caste lines and on race lines."Also on rt.com Covid-19 vaccine patent waiver ‘not a magic bullet,’ European Council chief warns
On Monday, some 450 public health experts, charities, faith leaders and others published an open letter calling on UK Prime Minister Boris Johnson to waive vaccine patents.
US President Joe Biden's administration said last week it backed proposals by India and South Africa at the World Trade Organization (WTO) to waive intellectual property rights on vaccines and other technologies.
The World Health Organization's Director-General Tedros Adhanom Ghebreyesus – who has previously called for nations to support such plans – said the US move marked a "monumental moment in the fight against Covid-19."Also on rt.com Russia ready to back waiving intellectual property rights for Covid vaccines, as Putin says now ‘not the time to maximize profits’
On Tuesday, Reuters reported that a spokesperson for the UK government had confirmed it was "engaging" with the US and other WTO members on the issue of waivers.
Like this story? Share it with a friend!